inmune
33.1K
Volume
+64%
Growth
peaked
About the Topic
Clinical-stage biotechnology company focused on harnessing the patient's immune system to treat cancer and other diseases. INmune Bio Inc. differentiates itself with its lead product, INKmune, which primes natural killer (NK) cells to kill cancer, offering a novel approach to immunotherapy. The company's primary target demographic includes patients suffering from cancer and other immune-related diseases, as well as healthcare providers seeking advanced treatment options.
inmune was discovered on April 22nd 2023 and it currently has a search volume of 33.1K with a growth of -38%.
Key Indicators
Growth
- Exploding
- Regular
- Peaked
Speed
- Exponential
- Constant
- Stationary
Seasonality
- High
- Medium
- Low
Volatility
- High
- Average
- Low
Members Only
Try Exploding Topics Pro
Get Free, Unlimited Access for 7 Days.
Categories
Save this topic and build your own trend dashboard.
Available with Exploding Topics Pro, try it now.
1.1M+ trends in our growing database.